JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
Year-over-year SG&A expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P31
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
4.75%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -100.00% |
| Q2 2025 | 42.34% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | 1.72% |
| Q2 2024 | -40.03% |
| Q1 2024 | 84.84% |
| Q4 2023 | 2.26% |
| Q3 2023 | 28.91% |
| Q2 2023 | -20.96% |
| Q1 2023 | 4.20% |
| Q4 2022 | -3.78% |
| Q3 2022 | 40.20% |
| Q2 2022 | -44.96% |
| Q1 2022 | 103.59% |
| Q4 2021 | 13.35% |
| Q3 2021 | -17.41% |
| Q2 2021 | 3.03% |
| Q1 2021 | 46.25% |
| Q4 2020 | 4.47% |
| Q3 2020 | -8.57% |
| Q2 2020 | -47.67% |
| Q1 2020 | 105.84% |
| Q4 2019 | 6.87% |
| Q3 2019 | -1.32% |
| Q2 2019 | -53.69% |
| Q1 2019 | 133.28% |
| Q4 2018 | -2.02% |
| Q3 2018 | 9.32% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q3 2015 | 0.00% |